Pumps specialist will strengthen its biopharmaceutical offering with the acquisition
Watson-Marlow Fluid Technology Group (WMFTG), a leader in niche peristaltic pumps and associated fluid path technologies, has acquired Asepco through its parent company Spirax-Sarco Engineering, for £7m.
Asepco, based in Mountain View, California, US, specialises in the design and manufacture of high purity aseptic valves and magnetic mixers for the bioprocessing industry.
WMFTG said Asepco is a natural extension of its fluid path product portfolio and further strengthens its global presence in the biotechnology and pharmaceutical industries.
Asepco joins a product range comprising Watson-Marlow Pumps, Watson-Marlow Tubing, Flexicon Filling Systems, BioPure single-use tubing connector systems, Alitea OEM Pumps, MasoSine Process Pumps and Bredel Hose Pumps.
WMFTG said there is 'clear synergy and a significant growth opportunity' presented by bringing together the two companies' products to meet the demands of the rapidly growing biopharmaceutical market.
Jay Whalen, President of the Watson-Marlow Fluid Technology Group, said: 'The strategic acquisition of Asepco further broadens our product range and strengthens Watson-Marlow's position in the biopharmaceutical market. This enables us to provide a more comprehensive and improved service to our customers looking for sterility throughout their fluid path.'
Steve Joy will remain in his role as President of Asepco. Prior to joining the company, he founded and grew a business with Jensen Fittings.